IL1B and glioblastoma: A group of mTOR antagonists (rapamycin, temsirolimus, torin-1, and PP242) significantly suppressed GBM cell invasion by blocking TME factors like IL1β, TNFα, MMP-2, and MMP-9 proteins [246].